Literature DB >> 8846421

Alterations in neurokinin 1 receptor gene expression in models of pain and inflammation.

J E Krause1, D A DiMaggio, K E McCarson.   

Abstract

Substance P and the related tachykinin peptides are involved in inflammatory processes and in the transmission of sensory nociceptive information. In this article we review the evidence implicating substance P and the neurokinin 1 (NK1) receptor in arthritic disease. We also provide preliminary evidence demonstrating that cultured synoviocytes from a patient with rheumatoid arthritis express NK1 receptor mRNA that can be downregulated by tumor necrosis factor alpha, whereas synoviocytes from a normal patient do not express detectable NK1 receptor mRNA or protein. Data are also presented summarizing recent studies on nociception-induced increases in sensory ganglia of levels of mRNA encoding substance P and increases in dorsal horn NK1 receptor mRNA levels. Morphine pretreatment blocked the increases in dorsal horn NK1 receptor mRNA levels but did not block the nociception-induced substance P encoding mRNA levels in sensory ganglia. These results are discussed with reference to mechanisms that may regulate P turnover and NK1 receptor sensitivity in models of pain and inflammation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8846421     DOI: 10.1139/y95-117

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  9 in total

Review 1.  [Peripheral mechanisms of joint pain with special focus on the synovial fibroblast].

Authors:  H Sprott
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

Review 2.  Transcriptional and posttranslational plasticity and the generation of inflammatory pain.

Authors:  C J Woolf; M Costigan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

3.  Neurotrophins: peripherally and centrally acting modulators of tactile stimulus-induced inflammatory pain hypersensitivity.

Authors:  R J Mannion; M Costigan; I Decosterd; F Amaya; Q P Ma; J C Holstege; R R Ji; A Acheson; R M Lindsay; G A Wilkinson; C J Woolf
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

4.  Neurokinin-1 receptor expression in inflammatory bowel disease: molecular quantitation and localisation.

Authors:  T Goode; J O'Connell; P Anton; H Wong; J Reeve; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

5.  Substance P enhances cytokine-induced vascular cell adhesion molecule-1 (VCAM-1) expression on cultured rheumatoid fibroblast-like synoviocytes.

Authors:  N Lambert; P L Lescoulié; B Yassine-Diab; G Enault; B Mazières; C De Préval; A Cantagrel
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

6.  Ethanol inhibits the binding of substance P to rat brain cortex NK1 receptors.

Authors:  S Scarrone; A Cappelli; A Cupello; M Matarrese; R M Moresco; F Fazio
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

7.  Prostaglandin E2 increases the expression of the neurokinin1 receptor in adult sensory neurones in culture: a novel role of prostaglandins.

Authors:  Gisela Segond von Banchet; Anita Scholze; Hans-Georg Schaible
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

8.  Role of tachykinin 1 and 4 gene-derived neuropeptides and the neurokinin 1 receptor in adjuvant-induced chronic arthritis of the mouse.

Authors:  Eva Borbély; Zsófia Hajna; Katalin Sándor; László Kereskai; István Tóth; Erika Pintér; Péter Nagy; János Szolcsányi; John Quinn; Andreas Zimmer; James Stewart; Christopher Paige; Alexandra Berger; Zsuzsanna Helyes
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 9.  Critical Neurotransmitters in the Neuroimmune Network.

Authors:  Thomas Wesley Hodo; Maria Teresa Prudente de Aquino; Akiko Shimamoto; Anil Shanker
Journal:  Front Immunol       Date:  2020-08-21       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.